<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A pathogenetic model of infantile <z:hpo ids='HP_0100021'>cerebral palsy</z:hpo> caused by maternal antiphospholipid (APS) syndrome has been elaborated </plain></SENT>
<SENT sid="1" pm="."><plain>Thirty-two children with <z:hpo ids='HP_0100021'>cerebral palsy</z:hpo> born to mothers with clinical signs of APS have been studied </plain></SENT>
<SENT sid="2" pm="."><plain>The basic clinical feature of <z:hpo ids='HP_0100021'>cerebral palsy</z:hpo> in children was the prevalence of the double hemiplegic form, the absence of severe <z:e sem="disease" ids="C0009241" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive disorders</z:e>, global muscular hypotrophy, rapid <z:hpo ids='HP_0001371'>contracture</z:hpo> formation and a tendency to frequent <z:e sem="disease" ids="C0035204" disease_type="Disease or Syndrome" abbrv="">respiratory diseases</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>A seropositive APS variant was found in 42% of mothers examined, the seronegative one--in 58% </plain></SENT>
<SENT sid="4" pm="."><plain>Such factors as (1) fetoplacental insufficiency and <z:mp ids='MP_0005039'>hypoxia</z:mp> caused by vascular infarctions of the placenta; (2) transplacental passage of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> from a mother to a child; (3) <z:hpo ids='HP_0001342'>intracerebral hemorrhages</z:hpo> and <z:e sem="disease" ids="C0023529" disease_type="Disease or Syndrome" abbrv="">periventricular leucomalacia</z:e> in infants play the key role in the pathogenesis of <z:hpo ids='HP_0100021'>cerebral palsy</z:hpo> in children born to mothers with APS </plain></SENT>
</text></document>